SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (3352)4/5/2001 2:58:17 PM
From: Biomaven  Respond to of 52153
 
Let me quote from his article:

I have no idea whether the bulk of common diseases will boil down to genes and proteins or germs. Neither does the average biotech investor. Does it make sense, therefore, to plunk investing dollars into companies that may or may not be central to the solution?

Well, if he thinks that's the crucial question determining whether most biotech companies are going to be successful, then I have to totally agree with him - he has no busines investing in biotech.

Peter



To: tuck who wrote (3352)4/5/2001 2:58:56 PM
From: Icebrg  Respond to of 52153
 
Amazing!



To: tuck who wrote (3352)4/5/2001 3:14:49 PM
From: Doc Bones  Read Replies (1) | Respond to of 52153
 
The many pronouncements on biotech by The Motley Fool have fully earned them advancement to the rank of Village Idiot.

Doc


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News